CENTRAL RETINAL ARTERY OCCLUSION
Clinical trials for CENTRAL RETINAL ARTERY OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new CENTRAL RETINAL ARTERY OCCLUSION trials appear
Sign up with your email to follow new studies for CENTRAL RETINAL ARTERY OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye injection aims to restore sight after sudden blindness
Disease control CompletedThis study tested an experimental drug called KUS121, given as an eye injection, for people who suddenly lost vision due to a blocked artery in the eye (central retinal artery occlusion). The goal was to see if the drug could improve vision better than a sham procedure. 17 adults…
Matched conditions: CENTRAL RETINAL ARTERY OCCLUSION
Phase: PHASE2 • Sponsor: Kyoto Drug Discovery and Development Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Clot-Busting drug shows promise for sudden blindness in eye artery blockage
Disease control CompletedThis study tested whether a clot-dissolving medicine called tenecteplase can restore vision in people who suddenly lose sight due to a blocked artery in the eye. 81 adults with central retinal artery occlusion received either tenecteplase or a placebo within 4.5 hours of symptoms…
Matched conditions: CENTRAL RETINAL ARTERY OCCLUSION
Phase: PHASE3 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 06, 2026 16:14 UTC